Larsen RH - Search Results

1

Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of 211At and 125I-labeled amidobisphosphonates in mice.

Murud KM, Larsen RH, Bruland OS, Hoff P. Murud KM, et al. Among authors: larsen rh. Nucl Med Biol. 1999 Oct;26(7):791-4. doi: 10.1016/s0969-8051(99)00047-5. Nucl Med Biol. 1999. PMID: 10628558

2

Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice.

Vergote I, Larsen RH, De Vos L, Winderen M, Ellingsen T, Bjørgum J, Hoff P, Aas M, Tropé C, Nustad K. Vergote I, et al. Among authors: larsen rh. Gynecol Oncol. 1992 Dec;47(3):358-65. doi: 10.1016/0090-8258(92)90140-e. Gynecol Oncol. 1992. PMID: 1473750

3

Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.

Vergote I, Larsen RH, de Vos L, Nesland JM, Bruland O, Bjørgum J, Alstad J, Tropé C, Nustad K. Vergote I, et al. Among authors: larsen rh. Gynecol Oncol. 1992 Dec;47(3):366-72. doi: 10.1016/0090-8258(92)90141-5. Gynecol Oncol. 1992. PMID: 1473751

4

Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model.

Larsen RH, Hoff P, Vergote IB, Bruland OS, Aas M, De Vos L, Nustad K. Larsen RH, et al. Gynecol Oncol. 1995 Apr;57(1):9-15. doi: 10.1006/gyno.1995.1093. Gynecol Oncol. 1995. PMID: 7705707

5

Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.

Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK. Larsen RH, et al. Radiat Res. 1994 Aug;139(2):178-84. Radiat Res. 1994. PMID: 8052693

6

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.

Larsen RH, Bruland OS, Hoff P, Alstad J, Rofstad EK. Larsen RH, et al. Br J Cancer. 1994 Jun;69(6):1000-5. doi: 10.1038/bjc.1994.196. Br J Cancer. 1994. PMID: 8198960 Free PMC article.

7

Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate.

Zalutsky MR, Stabin MG, Larsen RH, Bigner DD. Zalutsky MR, et al. Among authors: larsen rh. Nucl Med Biol. 1997 Apr;24(3):255-61. doi: 10.1016/s0969-8051(97)00060-7. Nucl Med Biol. 1997. PMID: 9228660

8

Cytotoxicity of alpha-particle-emitting 5-[211At]astato-2'-deoxyuridine in human cancer cells.

Larsen RH, Vaidyanathan G, Zalutsky MR. Larsen RH, et al. Int J Radiat Biol. 1997 Jul;72(1):79-90. doi: 10.1080/095530097143563. Int J Radiat Biol. 1997. PMID: 9246197

9

Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.

Larsen RH, Bruland OS. Larsen RH, et al. Br J Cancer. 1998 Apr;77(7):1115-22. doi: 10.1038/bjc.1998.185. Br J Cancer. 1998. PMID: 9569048 Free PMC article.

10

Blocking [211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds.

Larsen RH, Slade S, Zalutsky MR. Larsen RH, et al. Nucl Med Biol. 1998 May;25(4):351-7. doi: 10.1016/s0969-8051(97)00230-8. Nucl Med Biol. 1998. PMID: 9639296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results